论文部分内容阅读
加拿大多伦多消息:对一项茶碱类药物Enprofylline的国际性研究表明,此药是哮喘和慢性气道阻塞病患者有效的支气管扩张剂。据多伦多西部医院内科副教授KennethChapman说,Enprofylllne没有茶碱所引起的严重副作用。有待确定的问题是,此种新支气管扩张剂是否具有与茶碱相同的疗效,为此加拿大9个医疗中心的研究人员进行了一项两期临床试验。 Chapman说,Enprofyl-line没有严重的副作用,包括剂量过量时也没有发生癫痫的危险。与茶碱不同之处是,
TORONTO, CANADA: An international study of anophylline Enprofylline showed that it is a potent bronchodilator in asthma and chronic airway obstruction. According to Kenneth Chapman, an associate professor of internal medicine at Toronto Western Hospital, Enprofylllne has no serious side effects caused by theophylline. The question remains to be seen whether this new bronchodilator has the same efficacy as theophylline, and two of nine Canadian centers of medicine conducted a two-phase clinical trial. Chapman said Enprofyl-line has no serious side effects, including the risk of epilepsy not occurring when overdosage. The difference is that with theophylline,